Document is current
Any future updates will be listed below
-
Authors
Chen, Junyu
Hui, Qin
Titanji, Boghuma K.
So-Armah, Kaku
Freiberg, Matthew
Justice, Amy C.
Xu, Ke
Zhu, Xiaofeng
Gwinn, Marta
Marconi, Vincent C.
Sun, Yan V.
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125187)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125187)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK125187)
Center for AIDS Research, Emory University (P30AI050409)
- License Information
-
More Information
Article History
Received: 14 May 2024
Accepted: 14 October 2024
First Online: 2 November 2024
Declarations
:
: IRB approval for VACS was received from the institutional review boards of the coordinating center at Yale University, New Haven, CT, the Veterans Affairs (VA) Connecticut Healthcare System, West Haven, CT, and from the participating clinical sites. All participants have provided informed consent.
: All authors have read and approved the manuscript for publication.
: V.C.M. has received investigator-initiated research grants (to the institution) and consultation fees from Eli Lilly, Bayer, Gilead Sciences, Merck and ViiV.
